The Health Resources & Services Administration (“HRSA”) has allowed Provider Relief Fund (“Fund”) recipients who failed to timely report on use of Funds, but still retained them, to request to report late. We previously...more
The initial phase of Provider Relief Funds (“Funds”) was distributed in April 2020, and since then, many providers have been playing catch up. The Health Resources & Services Administration (HRSA) recently addressed two...more
On April 11, 2022, the Health Resources & Services Administration (“HRSA”) opened a portal that allows providers who were required to report on use of funds under Provider Relief Fund Reporting Period 1, but failed to do so,...more
The Health Resources and Services Administration (HRSA) recently posted an updated timeframe for disbursement of Phase 4 Provider Relief Funding (Funding). HRSA previously expected to begin disbursing Funding in mid-December...more
In a previous article, we discussed the Health Resources & Services Administration’s (HRSA) Phase 4 Provider Relief Funding (“Funding”). In the Funding announcement, HRSA and the Department of Health & Human Services (HHS)...more
Healthcare providers and related advocacy groups have been working for months to secure Phase 4 Provider Relief Funding (“Funds”). On September 10, 2021, the Department of Health & Human Services announced that it would make...more
As Provider Relief Fund (PRF) recipients look towards the end of the first PRF reporting period on September 30, 2021, the Department of Health & Human Services (HHS) and Health Resources & Services Administration (HRSA) have...more
A recent House bill, titled the "Closing Loopholes for Orphan Drugs Act," would narrow the exception for orphan drugs in the federal 340B Drug Pricing program. Representative Peter Welch (D-VT) introduced the bill on June 13,...more